Literature DB >> 22054889

A decade of advances in treatment of early-stage lung cancer.

Luca Paoletti1, Nicholas J Pastis, Chadrick E Denlinger, Gerard A Silvestri.   

Abstract

Emerging from the past decade, there has been a diversification of options for the treatment of early-stage lung cancer. Video-assisted thoracoscopic surgery is now more widely performed, with oncologic outcomes equivalent to those with open thoracotomy. Although lobectomy remains the standard approach to surgical resection, lesser resections, such as segmentectomy and wedge resection, are considerations for some patients. Advances in surgical, radiation, and medical therapies continue to evolve. Future research questions will focus on comparing long-term outcomes with these modalities, including survival, as well as patient-centered endpoints, such as quality of life. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22054889      PMCID: PMC3403691          DOI: 10.1016/j.ccm.2011.08.009

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  90 in total

Review 1.  Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

Authors:  Nam P Nguyen; Linda Garland; James Welsh; Russ Hamilton; Deirdre Cohen; Vincent Vinh-Hung
Journal:  Cancer Treat Rev       Date:  2008-07-26       Impact factor: 12.111

2.  The first total pneumonectomy.

Authors:  E A GRAHAM
Journal:  Tex Cancer Bull       Date:  1949 Jan-Feb

3.  Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Authors:  Gary M Strauss; James E Herndon; Michael A Maddaus; David W Johnstone; Elizabeth A Johnson; David H Harpole; Heidi H Gillenwater; Dorothy M Watson; David J Sugarbaker; Richard L Schilsky; Everett E Vokes; Mark R Green
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

4.  Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).

Authors:  Riccardo Lencioni; Laura Crocetti; Roberto Cioni; Robert Suh; Derek Glenn; Daniele Regge; Thomas Helmberger; Alice R Gillams; Andrea Frilling; Marcello Ambrogi; Carlo Bartolozzi; Alfredo Mussi
Journal:  Lancet Oncol       Date:  2008-06-17       Impact factor: 41.316

5.  Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.

Authors:  Katherine M W Pisters; William K Evans; Christopher G Azzoli; Mark G Kris; Christopher A Smith; Christopher E Desch; Mark R Somerfield; Melissa C Brouwers; Gail Darling; Peter M Ellis; Laurie E Gaspar; Harvey I Pass; David R Spigel; John R Strawn; Yee C Ung; Frances A Shepherd
Journal:  J Clin Oncol       Date:  2007-10-22       Impact factor: 44.544

6.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

7.  Surgical treatment for octogenarians with lung cancer: results from a population-based series of 124 patients.

Authors:  Hes A P Brokx; Otto Visser; Pieter E Postmus; Marinus A Paul
Journal:  J Thorac Oncol       Date:  2007-11       Impact factor: 15.609

8.  Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors.

Authors:  Daniel J Boffa; Mark S Allen; Joshua D Grab; Henning A Gaissert; David H Harpole; Cameron D Wright
Journal:  J Thorac Cardiovasc Surg       Date:  2007-12-21       Impact factor: 5.209

9.  Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.

Authors:  Gustavo Lyons; Silvia Quadrelli; Carlos Silva; Karina Vera; Alejandro Iotti; Julio Venditti; Julio Chertcoff; Domingo Chimondeguy
Journal:  J Thorac Oncol       Date:  2008-09       Impact factor: 15.609

10.  Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.

Authors:  Wulf Sienel; Sebastian Dango; Andreas Kirschbaum; Beatrix Cucuruz; Wolfram Hörth; Christian Stremmel; Bernward Passlick
Journal:  Eur J Cardiothorac Surg       Date:  2008-02-07       Impact factor: 4.191

View more
  11 in total

1.  Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway.

Authors:  Kyoung Ah Kang; Mei Jing Piao; Jin Won Hyun
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-08       Impact factor: 2.416

2.  Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival.

Authors:  Samir Soneji; Nichole T Tanner; Gerard A Silvestri; Christopher S Lathan; William Black
Journal:  Chest       Date:  2017-04-25       Impact factor: 9.410

3.  Thoracoscopic lobectomy versus open lobectomy in stage I non-small cell lung cancer: a meta-analysis.

Authors:  Yi-xin Cai; Xiang-ning Fu; Qin-zi Xu; Wei Sun; Ni Zhang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 4.  Carbon ion therapy for early-stage non-small-cell lung cancer.

Authors:  Yusuke Demizu; Osamu Fujii; Hiromitsu Iwata; Nobukazu Fuwa
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

5.  Features of fatigue in patients with early-stage non-small cell lung cancer.

Authors:  Xianping Huang; Weihe Zhou; Yuefeng Zhang
Journal:  J Res Med Sci       Date:  2015-03       Impact factor: 1.852

6.  Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.

Authors:  Mengyao Sun; Yang Bai; Song Zhao; Xiyu Liu; Yongsheng Gao; Lei Wang; Bin Liu; Dashi Ma; Chunye Ma
Journal:  Oncotarget       Date:  2018-01-04

7.  The arterial-ligation-alone method for identifying the intersegmental plane during thoracoscopic anatomic segmentectomy.

Authors:  Hong-Hao Fu; Zhen Feng; Meng Li; Hui Wang; Wan-Gang Ren; Zhong-Min Peng
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

8.  Long noncoding RNA PART1 promotes progression of non-small cell lung cancer cells via JAK-STAT signaling pathway.

Authors:  Dengyan Zhu; Yang Yu; Wei Wang; Kai Wu; Donglei Liu; Yang Yang; Chunyang Zhang; Yu Qi; Song Zhao
Journal:  Cancer Med       Date:  2019-08-22       Impact factor: 4.452

9.  Burden of air leak complications in thoracic surgery estimated using a national hospital billing database.

Authors:  Andrew Yoo; Sudip K Ghosh; Walter Danker; Edmund Kassis; Iftekhar Kalsekar
Journal:  Clinicoecon Outcomes Res       Date:  2017-06-29

10.  [Assessment of the Accuracy of Modified Inflation-deflation Methods for Distinguishing the Intersegmental Border].

Authors:  Haixing Wei; Yining Zhu; Qi Wang; Liang Chen; Weibing Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.